Stebėti
Anna Dąbrowska-Iwanicka
Anna Dąbrowska-Iwanicka
Maria Sklodowska-Curie Institute - Oncology Center
Patvirtintas el. paštas coi.waw.pl
Pavadinimas
Cituota
Cituota
Metai
Statins impair antitumor effects of rituximab by inducing conformational changes of CD20
M Winiarska, J Bil, E Wilczek, GM Wilczynski, M Lekka, PJ Engelberts, ...
PLoS medicine 5 (3), e64, 2008
1572008
Cardiotoxicity of the anticancer therapeutic agent bortezomib
D Nowis, M Mączewski, U Mackiewicz, M Kujawa, A Ratajska, ...
The American journal of pathology 176 (6), 2658-2668, 2010
1472010
Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicity
J Bil, M Winiarska, D Nowis, K Bojarczuk, A Dabrowska-Iwanicka, ...
Blood, The Journal of the American Society of Hematology 115 (18), 3745-3755, 2010
602010
Primary mediastinal large B-cell lymphoma
A Dabrowska-Iwanicka, JA Walewski
Current hematologic malignancy reports 9 (3), 273-283, 2014
562014
Synergistic antitumor effects of a selective proteasome inhibitor and TNF in mice.
WS Golab J, Stoklosa T, Czajka A, Dabrowska A, Jakobisiak M, Zagozdzon R ...
Anticancer Res. 2000 May-Jun;20(3A):1717-21, 2000
51*2000
Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)—Polish compassionate use experience
GW Basak, W Knopinska-Posluszny, M Matuszak, E Kisiel, D Hawrylecka, ...
Annals of hematology 90, 557-568, 2011
422011
First‐line R‐CVP versus R‐CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by …
J Walewski, E Paszkiewicz‐Kozik, W Michalski, G Rymkiewicz, T Szpila, ...
British journal of haematology 188 (6), 898-906, 2020
262020
Hematología
T Robak, K Warzocha
Via Medica, 2016
252016
Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies
M Winiarska, K Bojarczuk, B Pyrzynska, J Bil, M Siernicka, M Dwojak, ...
MAbs 6 (5), 1300-1313, 2014
212014
Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor
A Sureda, C Chabannon, T Masszi, D Pohlreich, C Scheid, C Thieblemont, ...
Bone marrow transplantation 55 (3), 613-622, 2020
162020
Augmented antitumour effects of combination therapy with TNP-470 and chemoimmunotherapy in mice
A Dabrowska-Iwanicka, D Olszewska, A Jalili, M Makowski, T Grzela, ...
Journal of cancer research and clinical oncology 128, 433-442, 2002
92002
Treatment of primary mediastinal B-cell lymphoma-a multicenter retrospective analysis on behalf of the Polish Lymphoma Research Group
A Dąbrowska-Iwanicka, A Giza, W Jurczak, A Polakiewicz-Gilowska, ...
Annals of Oncology 22 (suppl. 4), 2011
62011
Observation vs. radiotherapy in primary mediastinal B-cell lymphoma patients with complete response to standard immunochemotherapy: The IELSG37 randomized trial.
E Zucca, A Davies, I Kryachok, G Ciccone, L Ceriani, B Botto, ...
Journal of Clinical Oncology 41 (17_suppl), LBA7505-LBA7505, 2023
52023
Efficacy of siltuximab in the treatment of idiopathic multicentric castleman disease, the first Polish, real-world experience with long-term observation
B Ostrowska, A Szymczyk, M Olszewska-Szopa, J Romejko-Jarosińska, ...
Leukemia & Lymphoma 62 (12), 3031-3034, 2021
52021
High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow up
J Romejko-Jarosinska, B Ostrowska, A Dabrowska-Iwanicka, ...
Scientific Reports 12 (1), 10551, 2022
32022
Safety and efficacy of induction immunochemotherapy with rituximab, methotrexate, ifosfamide, and vincristine (R‐MIV) in patients with primary CNS lymphoma including …
B Ostrowska, K Domanska‐Czyz, J Romejko‐Jarosinska, M Osowiecki, ...
British Journal of Haematology 201 (4), 663-672, 2023
22023
DA-EPOCH-R Is an Effective Regimenin High Grade B-Cell Lymphoma Defined By Cell-of-Origin, Karyotype and BCL2/MYC/BCL6 Status and Expression
G Rymkiewicz, J Romejko-Jarosinska, K Blachnio, B Grygalewicz, ...
Blood, The Journal of the American Society of Hematology 128 (22), 1754-1754, 2016
22016
Primary mediastinal B-cell lymphoma treated with intensive chemotherapy and rituximab compared to CHOP—15 year experience from a single institution
AP Dąbrowska-Iwanicka, J Romejko-Jarosiśska, B Ostrowska, ...
Journal of Clinical Oncology 26 (15_suppl), 19506-19506, 2008
22008
DLBCL: Who is high risk and how should treatment be optimized?
AP Dabrowska-Iwanicka, GS Nowakowski
Blood Journal, blood. 2023020779, 2023
12023
S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 …
M Martelli, L Ceriani, E Zucca, I Kryachok, G Ciccone, U Ricardi, B Botto, ...
Hemasphere 7, e2454568, 2023
12023
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–20